|
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Next
|
|
| |
|
Jan '03
|
|
Opportunistic Infection Prophylaxis Can Be Safely Dropped After CD4 Recovery
| |
Therapy to prevent opportunistic infection relapses in HIV patients is often unnecessary after antiretroviral treatment, according to researchers in Europe. |
|
|
Dec '02
|
|
Researchers May Have Unlocked a Key HIV Mystery
| |
University of Minnesota researchers may have unlocked another key mystery surrounding HIV. Their discovery appears to explain why a quarter of HIV patients respond poorly to
drug cocktails while others show dramatic improvements. |
|
|
Dec '02
|
|
Hair Sample May Give Clues to Drug Response
| |
Doctors can get a handle on how well an HIV-infected person is responding to antiretroviral drugs as well as whether or not they are actually taking their medicine by testing a
sample of the patient's hair, researchers report. |
|
|
Dec '02
|
|
Lipodystrophy Study Looks at Mitochondrial Toxicity
| |
Highly active antiretroviral therapy (HAART) has been associated with the development of lipodystrophy syndromes. Lipodystrophy, a clinical condition characterized by poor or
uneven distribution of fat cells, can lead to lower belly obesity and a hump on the upper back. |
|
|
Dec '02
|
|
Long-Term Interruption of HIV Treatment May Be Safe in Certain Patients
| |
Interrupting HIV treatment for an extended period and then re-initiating therapy might be safe in certain patients, according to a study by infectious disease experts. |
|
|
Nov '02
|
|
T-20 May Help Expand Treatable Groups
| |
New findings suggest that an AIDS drug being developed for patients who become resistant to standard treatments may benefit wider groups of people with AIDS. |
|
|
Nov '02
|
|
HIV Patients Do Well with Organ Transplants
| |
Researchers report that patients with HIV are successfully receiving liver and kidney transplants, challenging widespread reluctance by transplant centers to give scarce organs to
people with incurable disease. |
|
|
Nov '02
|
|
Novel Nucleoside Analog Active Against Drug-Resistant Strains
| |
Researchers in the United States may have found a way to augment antiretroviral therapy's effectiveness against drug- resistant HIV strains. The cytidine nucleoside analog DPC
817 remains effective against viruses with resistance mutations countering reverse transcriptase inhibitors, a crucial element of HAART, according to researchers. |
|
|
Nov '02
|
|
No Benefit to Drug Holidays?
| |
Despite hopes that taking regularly scheduled breaks from combination therapy would train the immune system to keep HIV under control, a new study fails to detect any benefit of
such drug holidays. |
|
|
Nov '02
|
|
Fumagillin Effective for Microsporidiosis
| |
The fungal antibiotic fumagillin can resolve intractable intestinal infections in HIV patients and others, according to researchers in France. |
|
|
Oct '02
|
|
Drug Halt Can Reduce Resistance in Late-stage AIDS
| |
Advanced AIDS patients who have become resistant to treatment with all available HIV drugs might benefit from strictly controlled treatment interruptions, Dr. Christine Katlama
of Hospital Pitie-Salpetriere in Paris said at the 14th International AIDS Conference. |
|
|
Oct '02
|
|
Sexual Dysfunction in HIV-positive Men on HAART
| |
Sexual dysfunction in HIV patients has rarely been studied; sexual function has mostly been studied in this population with respect to HIV transmission. |
|
|
Oct '02
|
|
Study Finds More HIV Shedding in Semen
| |
It has long been hypothesized that semen viral load is the explanation for why there appears to be greater HIV transmission associated with acute infection. |
|
|
Oct '02
|
|
Tell us about your scrotum!
| |
Is the scrotum a sex organ? Almost no one ever talks about it. While the cock has a thousand names, the ball-bag hangs behind in relative obscurity. |
|
|
Oct '02
|
|
HIV Linked to Increased Risk of Blood Clots
| |
People with HIV who are younger than 50 may be at an increased risk of potentially fatal blood clotting, called venous thrombosis, suggests a study published in the May issue of
AIDS Patient Care and STDs. |
|
|
Oct '02
|
|
Jeb Bush's Veto of Methadone $ Throws Addicts onto Streets
| |
A decision made earlier this summer by Gov. Jeb Bush to veto a $1 million appropriation for three South Florida methadone clinics could affect more than the patients who depend
on their daily dose of the heroin substitute, critics say. |
|
|
Oct '02
|
|
New Guidelines Suggest Drug Treatment Can Be Delayed
| |
New treatment guidelines suggest symptom-free HIV patients can wait longer than previously recommended to begin taking AIDS drugs. The new guidelines appear in the July 10th
issue of the Journal of the American Medical Association. |
|
|
Sep '02
|
|
Painful Bone Problem More Common in HIV Patients
| |
Around 4 percent of HIV-positive patients may unknowingly have the bone disorder osteonecrosis, a potentially painful and debilitating condition. |
|
|
Sep '02
|
|
AIDS Drug to Fight Hepatitis
| |
The Food and Drug Administration's Antiviral Drugs Advisory Panel voted unanimously to recommend approval of a new drug for hepatitis B, a potentially life-threatening liver ailment that afflicts more than 1 million Americans. |
|
|
Sep '02
|
|
Prison Rapes Spread HIV
| |
Rape has become so common in US federal and state prisons that it could have deadly consequences for the inmate population as well as the public at large, according to experts. Prison rape has been associated with the spread of diseases such as AIDS and TB. |
|
|
Sep '02
|
|
Drug Resistance Among Recently Infected
| |
Among persons in North America who are newly infected with HIV, the prevalence of transmitted resistance to antiretroviral drugs has been estimated at 1 to 11 percent. |
|
|
Sep '02
|
|
Tight T-20 Supply
| |
The Swiss pharmaceutical company Roche said that tight supplies of its HIV drug candidate Fuzeon, known as T-20, mean only a limited number of patients will have access to it at first. |
|
|
Aug '02
|
|
News of super-infection case
| |
Grim findings presented at the 14th International Conference on AIDS put a successful AIDS vaccine even further off on the horizon. |
|
|
Aug '02
|
|
AIDS drugs harden arteries?
| |
Researchers have discovered direct toxicity of protease inhibitors (PIs) to the endothelial cells that line blood vessels. |
|
|
Aug '02
|
|
Your dick on HIV drugs...
| |
Protease inhibitor (PI)-based combination antiretroviral therapy has been associated with metabolic and endocrinologic adverse effects that were not apparent during pre-marketing clinical trials, such as hyperlipidemia,
insulin resistance, and body fat redistribution. |
|
|
Jul '02
|
|
Norway Cabs Hand Out Condoms
| |
A Norwegian taxi firm is promoting safe sex by handing out free condoms to any client who asks. |
|
|
Jul '02
|
|
Antiretroviral Treatment May Restore Thymic Function
| |
Powerful antiretroviral therapy for HIV infection can help restore thymic function in treated patients, researchers in Spain report. |
|
|
Jul '02
|
|
Kompassionate Konservative?
| |
Florida Gov. Jeb Bush cut $110 million from the state budget and signed into law a $50 billion spending plan for the coming year. |
|
|
Jul '02
|
|
Speed Boosts HIV in Brain?
| |
The drug methamphetamine dramatically increases the ability of feline immunodeficiency virus, or FIV, to reproduce itself in a type of brain cell in cats, new research reveals. If
the findings hold true in humans, they could help explain why AIDS progresses more rapidly in drug abusers. |
|
|
Jul '02
|
|
Researchers Develop HIV Fighter
| |
A form of ribonucleic acid (RNA) developed by researchers at the Massachusetts Institute of Technology has the potential to be a new weapon against HIV. The short form of RNA
turns off genes vital to the production of proteins HIV uses to enter and infect cells. |
|
|
|
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Next
|
Advertise with us
Subscriptions
Contact us
Site map
Translate
